Anagenex, which mixes AI and large-scale proprietary datasets for drug discovery, has raised a $30M Sequence A led by Catalio Capital Administration (Arundhati Parmar/MedCity Information)

Arundhati Parmar / MedCity Information:

Anagenex, which mixes AI and large-scale proprietary datasets for drug discovery, has raised a $30M Sequence A led by Catalio Capital Administration  —  The CEO of Anagenex believes that the corporate’s AI engine skilled on billions of knowledge factors and iterative testing will blow different AI drug discovery startups out of the water.